Published in Mal Cardiovasc on January 01, 1967
Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart. Br J Pharmacol (2006) 0.81
A kallidin-like peptide is a protective cardiac kinin, released by ischaemic preconditioning of rat heart. Br J Pharmacol (2005) 0.78
Role of kinins in the mechanism of the sterile carditis from myocardial infarction [proceedings]. Agents Actions (1978) 0.75
Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice. J Reticuloendothel Soc (1973) 1.66
Amplifying effect of sumatriptan on noradrenaline venoconstriction in migraine patients. Cephalalgia (1993) 1.41
[On post-traumatic ptosis]. Rev Stomatol Chir Maxillofac (2003) 1.40
Hypothalamic modulation of nociception and reproduction in cluster headache. I. Therapeutic trials of leuprolide. Cephalalgia (1993) 1.30
Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man. Br J Pharmacol (1988) 1.23
Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia (2009) 1.18
Hypothalamic modulation of nociception and reproduction in cluster headache. II. Testosterone-induced increase of sexual activity in males with cluster headache. Cephalalgia (1993) 1.17
Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia (1999) 1.13
Lowered circannual urinary melatonin concentrations in episodic cluster headache. Cephalalgia (1994) 1.12
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer (2006) 1.10
Visceral pain threshold is deeply lowered far from the head in migraine. Headache (1994) 1.06
Interaction and dialogue between the users and the patient record core of hospital information system: looking for a solution. Proc Annu Symp Comput Appl Med Care (1995) 1.04
An enzyme (MAO) defect on the platelets in migraine. Res Clin Stud Headache (1970) 1.04
Assessing users' satisfaction through perception of usefulness and ease of use in the daily interaction with a hospital information system. Proc AMIA Annu Fall Symp (1996) 1.01
Chemotherapy of a spontaneous mammary carcinoma in mice: relation between in vitro-in vivo activity and blood and tumor concentrations of serveral antitumor drugs. Cancer Chemother Rep (1973) 1.00
Hyperresponsiveness of migraine patients to the hypotensive action of bromocriptine. Headache (1980) 0.98
Effect of Triton WR 1339 on cancer dissemination and metastases. Eur J Cancer (1969) 0.98
Unilateral impairment of pupillary response to trigeminal nerve stimulation in cluster headache. Pain (1989) 0.96
Characterization of the immunostimulants levamisole and tetramisole. Eur J Cancer (1975) 0.94
Impairement of drug metabolism in tumor-bearing animals. Eur J Cancer (1971) 0.94
Headache as possible expression of deficiency of brain 5-hydroxytryptamine (central denervation supersensitivity). Headache (1972) 0.94
Visual responses in the dorsal premotor area F2 of the macaque monkey. Exp Brain Res (1999) 0.91
Dopamine, the second putative protagonist in headache. Headache (1977) 0.91
An antaminic drug, BC 105, in the prophylaxis of migraine. Pharmacological, clinical, and therapeutic experiences. Int Arch Allergy Appl Immunol (1967) 0.90
[The test of venoconstriction for the measurement of sensitivity to 5-hydroxytryptamine and catecholamines in man]. Boll Soc Ital Biol Sper (1964) 0.90
Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone. J Med Chem (1975) 0.89
The naloxone conjunctival test in morphine addiction. Eur J Pharmacol (1980) 0.89
Motor responses mediated by orthodromic and antidromic activation of the rostral portion of the cat corpus callosum. Exp Brain Res (1986) 0.89
[A pediatric case of Alveolar Soft Part Sarcoma]. Rev Stomatol Chir Maxillofac (2007) 0.89
Central cholinergic challenging of migraine by testing second-generation anticholinesterase drugs. Headache (2002) 0.88
Hypothesis: migraine, a central biochemical dysnociception. Headache (1976) 0.88
Enkephalinase inhibition relieves pain syndromes of central dysnociception (migraine and related headache). Cephalalgia (1981) 0.87
The effect of cytotoxic agents on drug metabolism. Eur J Cancer (1970) 0.87
Systemic non-organic central pain: a new syndrome with decentralization supersensitivity. Headache (1978) 0.86
Sex, migraine and serotonin interrelationships. Monogr Neural Sci (1976) 0.86
Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty. Eur J Pediatr (1993) 0.85
In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF. Eur J Pharmacol (1986) 0.85
Multiple aspects of headache risk in children. Adv Neurol (1982) 0.85
Characterization of endopeptidase 3.4.24.11 ("enkephalinase") activity in human plasma and cerebrospinal fluid. Biochem Pharmacol (1990) 0.85
Ergotamine and methysergide as serotonin partial agonists in migraine. Headache (1976) 0.85
The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatriptan. J Pharmacol Exp Ther (1996) 0.84
Does anisocoria by clonidine reflect a central sympathetic dysfunction in cluster headache? Clin Neuropharmacol (1988) 0.84
Unmasking latent dysnociception in healthy subjects. Headache (1987) 0.84
Endorphins, opiate receptors and migraine headache. Headache (1978) 0.82
Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy. Epidemiol Infect (1998) 0.82
Selective chemotherapy of cancer metastases with triton WR 1339. Eur J Cancer (1971) 0.82
Fibromyalgia and headache. Failure of serotonergic analgesia and N-methyl-D-aspartate-mediated neuronal plasticity: their common clues. Cephalalgia (1998) 0.82
Wine and migraine: compatibility or incompatibility? Drugs Exp Clin Res (1999) 0.81
Triton WR 1339 (TWR), an inhibitor of cancer dissemination and metastases. Eur J Cancer (1971) 0.81
Alpha and beta adrenergic receptors in human veins; activity of a new beta-blocking agent. Med Pharmacol Exp Int J Exp Med (1966) 0.81
Decentralization supersensitivity in headache and central panalgesia. Res Clin Stud Headache (1978) 0.81
Classification and diagnostic criteria for primary headache disorders (Ad Hoc Committee IHS, 1988). Funct Neurol (1989) 0.81
Pain relief by somatostatin in attacks of cluster headache. Pain (1984) 0.80
Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol (1994) 0.80
Metabolic fate of zoxazolamine in tumor bearing rats. Biochem Pharmacol (1969) 0.80
5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine. Psychopharmacologia (1973) 0.80
Rehabilitation of the paralysed or lax lower eyelid using a graft of conchal cartilage. Br J Plast Surg (2002) 0.80
Morphine abstinence and serotonin supersensitivity in man: analogies with the mechanism of migraine? Psychopharmacology (Berl) (1979) 0.80
[Fracture of the medial wall of the orbit. Apropos of 4 cases]. Rev Stomatol Chir Maxillofac (1995) 0.79
Analgesizing effect of a methyl donor (S-adenosylmethionine) in migraine: an open clinical trial. Int J Clin Pharmacol Res (1986) 0.79
Experimental chemotherapy of a transplantable rhabdomyosarcoma in the rat. Eur J Cancer (1970) 0.79
Substance P and endogenous opioids: how and where they could play a role in cluster headache. Cephalalgia (1983) 0.79
Spreading the clinical information system: which users are satisfied? Stud Health Technol Inform (1997) 0.79
Fenfluramine headache. Headache (1976) 0.79
Somatostatin: peripheral venoconstrictive activity and interaction with monoamines in man. Regul Pept (1987) 0.79
Personality patterns of headache sufferers. Cephalalgia (1983) 0.79
Change in serotonin and catecholamines vascular reactivity during migraine attack. Res Clin Stud Headache (1970) 0.79
A statistical evaluation of the relationships between headache and internal frontal hyperostosis. Res Clin Stud Headache (1970) 0.79
Latent dysautonomic pupillary lateralization in cluster headache. A pupillometric study. Cephalalgia (1982) 0.79
Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. Int J Clin Pharmacol Res (1997) 0.79
A new nonvascular interpretation of syncopal migraine. Adv Neurol (1982) 0.79
A computerized guideline for pressure ulcer prevention. Int J Med Inform (2000) 0.78
Commercial kits for 1,25-dihydroxyvitamin D compared with a liquid-chromatographic assay. Clin Chem (1993) 0.78
Release of sensory neuropeptides from dural venous sinuses of guinea pig. Brain Res (1990) 0.78
The inhibitory effect of cancer cell dissemination on the phagocytic acitivity of the reticuloendothelial system in tumor-bearing mice. J Reticuloendothel Soc (1972) 0.78
Adrenergic supersensitivity of the pupil in idiopathic headache. Experientia (1977) 0.78
Acute oral captopril inhibits angiotensin converting enzyme activity in human cerebrospinal fluid. J Hypertens (1987) 0.78
Substance P mechanism in cluster headache: evaluation in plasma and cerebrospinal fluid. Cephalalgia (1985) 0.78
Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy. Adv Exp Med Biol (1996) 0.78
Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-demethoxy-4' -epiadriamycin. Cancer Treat Rep (1978) 0.78
[Clinical pharmacology of pindolol on vasomotor receptors]. Boll Soc Ital Biol Sper (1975) 0.78
Thiorphan increases capsaicin-evoked release of substance P from slices of dorsal spinal cord of guinea pig. Neurosci Lett (1989) 0.78
[Inhibition of venoconstriction induced by 5-hydroxytryptamine in man by methysergide (UMI-491) and other serotonin antagonists]. Boll Soc Ital Biol Sper (1964) 0.77
Intermittent hypoendorphinaemia in migraine attack. Cephalalgia (1982) 0.77
Enkephalinase and angiotensin converting enzyme activities in human venous and arterial plasma. Neuropeptides (1986) 0.77